SUBSTITUTED PHENYLIMIDAZOLIDINE, PROCESS FOR PREPARATION THEREOF, USE THEREOF AS MEDICINE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
PURPOSE: Provided is a substituted phenylimidazolidine, which inhibits androgenic activity in warm-blooded animals. Further, a process for the preparation of the substituted phenylimidazolidine and an anti-androgenic composition containing it are provided. CONSTITUTION: The substituted phenylimidazo...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
17.09.2001
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PURPOSE: Provided is a substituted phenylimidazolidine, which inhibits androgenic activity in warm-blooded animals. Further, a process for the preparation of the substituted phenylimidazolidine and an anti-androgenic composition containing it are provided. CONSTITUTION: The substituted phenylimidazolidine is represented by the formula I, wherein R1 is -CN, -NO2 or halogen, R2 is -CF3 or halogen, -A-B- is selected from the group consisting of formula II, III (in which X is -O- or -S-, R3 is hydrogen, hydroxy, halogen, unsubstituted or substituted aryl, -O-aryl, -O-aralkyl, -S-aryl, free carboxy, esterified carboxy, trialkylsilyl or acyl), and Y is -O-, -S- or =NH, except the compounds of the formula I wherein -A-B- is formula II (in which, X is oxygen, R3 is hydrogen) and Y is oxygen or =NH, R2 is -CF3 or halogen and R1 is -NO2 or halogen.
본 발명은 하기 일반식(I)의 신규의 치환 페닐이미다졸리딘, 이들의 제조 방법, 의약으로서의 용도 및 이들을 함유하는 제약 조성물에 관한 것이다. |
---|---|
AbstractList | PURPOSE: Provided is a substituted phenylimidazolidine, which inhibits androgenic activity in warm-blooded animals. Further, a process for the preparation of the substituted phenylimidazolidine and an anti-androgenic composition containing it are provided. CONSTITUTION: The substituted phenylimidazolidine is represented by the formula I, wherein R1 is -CN, -NO2 or halogen, R2 is -CF3 or halogen, -A-B- is selected from the group consisting of formula II, III (in which X is -O- or -S-, R3 is hydrogen, hydroxy, halogen, unsubstituted or substituted aryl, -O-aryl, -O-aralkyl, -S-aryl, free carboxy, esterified carboxy, trialkylsilyl or acyl), and Y is -O-, -S- or =NH, except the compounds of the formula I wherein -A-B- is formula II (in which, X is oxygen, R3 is hydrogen) and Y is oxygen or =NH, R2 is -CF3 or halogen and R1 is -NO2 or halogen.
본 발명은 하기 일반식(I)의 신규의 치환 페닐이미다졸리딘, 이들의 제조 방법, 의약으로서의 용도 및 이들을 함유하는 제약 조성물에 관한 것이다. |
Author | TEUTSCH JEAN-GEORGES GAILLARD-KELLY MARTINE PHILIBERT DANIEL GOUBET FRANCOIS GOUBET |
Author_xml | – fullname: GAILLARD-KELLY MARTINE – fullname: PHILIBERT DANIEL – fullname: GOUBET FRANCOIS GOUBET – fullname: TEUTSCH JEAN-GEORGES |
BookMark | eNqNjL0OgkAQhCm08O8dNrHFRMVCy-VYZCN3R-6OQhtCzFkZINHH8KEFo73VzCTfN9Ng1LSNnwQvW8bWsSsdJVBkpM45S07wonNOWFEIhdGCrIVUm75TgQYdawUuI0M6DaG09BuAFiQlLHoTUA2PaCQKKh0LzEFoWWjLH19o5ZAVq-Ngg0VJ82B8q-8Pv_jmLFim5ES28l1b-UdXX33jn9XJbNbr7WEX7aM43kT_UW9RKEKa |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 치환페닐이미다졸리딘,이들의제조방법,의약으로서의용도및이들을함유하는제약조성물 |
Edition | 7 |
ExternalDocumentID | KR100294383BB1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR100294383BB13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:24:45 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR100294383BB13 |
Notes | Application Number: KR19930009431 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010917&DB=EPODOC&CC=KR&NR=100294383B1 |
ParticipantIDs | epo_espacenet_KR100294383BB1 |
PublicationCentury | 2000 |
PublicationDate | 20010917 |
PublicationDateYYYYMMDD | 2001-09-17 |
PublicationDate_xml | – month: 09 year: 2001 text: 20010917 day: 17 |
PublicationDecade | 2000 |
PublicationYear | 2001 |
RelatedCompanies | ROUSSEL-UCLAF |
RelatedCompanies_xml | – name: ROUSSEL-UCLAF |
Score | 2.507792 |
Snippet | PURPOSE: Provided is a substituted phenylimidazolidine, which inhibits androgenic activity in warm-blooded animals. Further, a process for the preparation of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | SUBSTITUTED PHENYLIMIDAZOLIDINE, PROCESS FOR PREPARATION THEREOF, USE THEREOF AS MEDICINE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010917&DB=EPODOC&locale=&CC=KR&NR=100294383B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEN401ag3rRof1Wyi4dTGtFIoB2KWZRGs7BIepnppoKWJadI2FuOf8Ec7i8V66m2BzCQMmdn5lplvELrt9zWIvIYOXyAFgJLJaYC9qdZO02yaj7uZbMaU1RZccxP1adgb1tCs6oUpeUK_SnJE8Kgx-HtRxuvl5hDLLmsrV3fZO9xaPDixaSsVOpY0l7piWyYLhC2oQqk5CBUempJp1JC0nBZApR3Io3XpDuzFkm0py_97inOIdgNQNy-OUG22aKB9Wo1ea6A9f_3HG5Zr51sdo-8osaLYixMINjhwGX-Vkccmb-LZsz3OWjgIBQWDYkB2sGYB-T2BwrHLQiacFk4iVl1gEuGS2xEkMeFSIwl9QlkSS4oETIUfiMgr5angMfG4xx-lNI6Iz07QjcNi6rbhtUZ_RhwNwo0JrM79KarPF_P8DOEUEopUlcOmu7maAmDIjUzXswmkVhNV6-fnqLlN08X2x5fo4Ldqy2h39CaqFx-f-RVs40V2XZr_BwMolkI |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8IGvFNUeMHahPNniAGHBt7WEzXdW7CumUfBn0hG4zEkACRGf8J_2ivg4lPvHVd7pJec9e79u53CN33egpYXk2FHUggQElFN8DuVGklSTrNxp1UFGOKbAuu2LH8MuwOK2hW1sIUOKHfBTgiaNQY9D0v7PVye4llFrmVq4f0A6YWT1akm1IZHQuYS1UyDZ35nulRiVK9H0g80AXSqCZgOQ0IlfbAx1aFOrBXQ5SlLP-fKdYR2veB3Tw_RpXZoo5qtGy9VkcH7ubFG4Yb5VudoJ8wNsLIiWIwNti3GX8Tlsck797AMR3OmtgPPAoCxRDZwZj5ZH0DhSObBcyzmjgOWfmBSYgLbEegxIQLjiRwCWVxJCASMPVc3wudgp56PCIOd_izoMYhcdkpurNYRO0WLGv0J8RRP9iKwGg_nqHqfDHPzhFOwKFIZNFsupPJCQQMmZaqajoB12oiK73sAjV2cbrc_fsW1ezIHYwGDu9focN1BpfWaqsNVM0_v7JrONLz9KbYil89fpk1 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+PHENYLIMIDAZOLIDINE%2C+PROCESS+FOR+PREPARATION+THEREOF%2C+USE+THEREOF+AS+MEDICINE+AND+PHARMACEUTICAL+COMPOSITION+CONTAINING+THE+SAME&rft.inventor=GAILLARD-KELLY+MARTINE&rft.inventor=PHILIBERT+DANIEL&rft.inventor=GOUBET+FRANCOIS+GOUBET&rft.inventor=TEUTSCH+JEAN-GEORGES&rft.date=2001-09-17&rft.externalDBID=B1&rft.externalDocID=KR100294383BB1 |